Cargando…
The dosing conundrum of emicizumab: To waste product or not?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999193/ https://www.ncbi.nlm.nih.gov/pubmed/36908771 http://dx.doi.org/10.1016/j.rpth.2023.100087 |
| _version_ | 1784903614568857600 |
|---|---|
| author | Young, Guy |
| author_facet | Young, Guy |
| author_sort | Young, Guy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9999193 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99991932023-03-11 The dosing conundrum of emicizumab: To waste product or not? Young, Guy Res Pract Thromb Haemost Commentary Elsevier 2023-02-16 /pmc/articles/PMC9999193/ /pubmed/36908771 http://dx.doi.org/10.1016/j.rpth.2023.100087 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Commentary Young, Guy The dosing conundrum of emicizumab: To waste product or not? |
| title | The dosing conundrum of emicizumab: To waste product or not? |
| title_full | The dosing conundrum of emicizumab: To waste product or not? |
| title_fullStr | The dosing conundrum of emicizumab: To waste product or not? |
| title_full_unstemmed | The dosing conundrum of emicizumab: To waste product or not? |
| title_short | The dosing conundrum of emicizumab: To waste product or not? |
| title_sort | dosing conundrum of emicizumab: to waste product or not? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999193/ https://www.ncbi.nlm.nih.gov/pubmed/36908771 http://dx.doi.org/10.1016/j.rpth.2023.100087 |
| work_keys_str_mv | AT youngguy thedosingconundrumofemicizumabtowasteproductornot AT youngguy dosingconundrumofemicizumabtowasteproductornot |